Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Sci Rep ; 6: 32038, 2016 08 25.
Artículo en Inglés | MEDLINE | ID: mdl-27559010

RESUMEN

Werner syndrome (WS) is the canonical adult human progeroid ('premature aging') syndrome. Patients with this autosomal recessive Mendelian disorder display constitutional genomic instability and an elevated risk of important age-associated diseases including cancer. Remarkably few analyses of WS patient tissue and tumors have been performed to provide insight into WS disease pathogenesis or the high risk of neoplasia. We used autopsy tissue from four mutation-typed WS patients to characterize pathologic and genomic features of WS, and to determine genomic features of three neoplasms arising in two of these patients. The results of these analyses provide new information on WS pathology and genomics; provide a first genomic characterization of neoplasms arising in WS; and provide new histopathologic and genomic data to test several popular models of WS disease pathogenesis.


Asunto(s)
Mutación , Síndrome de Werner/genética , Síndrome de Werner/patología , Adulto , Senescencia Celular , ADN Mitocondrial , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neoplasias/genética , Telómero/genética , Helicasa del Síndrome de Werner/genética
3.
Hawaii Med J ; 70(3): 52-5, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21365542

RESUMEN

Werner's Syndrome (WS) or adult-onset progeria is an autosomal recessive disorder of accelerated aging caused by mutations of the DNA RecQ helicase/exonuclease (WRN). WRN is an ATP-dependent helicase with 3' to 5' DNA exonuclease activity that regulates the replicative potential of dividing cells, and WRN loss-of-function mutations promote cellular senescence and neoplastic transformation. These molecular findings translate clinically into adult-onset progeria manifested by premature hair graying, dermal atrophy, cardiovascular disease, and cancer predilection along with a markedly reduced life expectancy. Recently, a patient with WS who developed pancreatic adenocarcinoma was identified in Honolulu suggesting a significant prevalence of loss-of-function WRN mutations in Hawaii's Japanese-American population. Based upon the indigenous Japanese WRN loss-of-function mutation heterozygote rate of 6 per 1,000, we speculate the possibility of approximately 1,200 heterozygotes in Hawaii. Our ongoing studies aim to evaluate Hawaii's true allelic prevalence of WRN loss-of-function mutations in the Japanese-American population, and the role of WRN silencing in sporadic cancers. In summary, WRN plays a nexus-like role in the complex interplay of cellular events that regulate aging, and analysis of WRN polymorphisms in Hawaii's population will generate novel insights to advance care for age-related pathologies.


Asunto(s)
Envejecimiento/genética , Exodesoxirribonucleasas/genética , Exonucleasas/genética , Neoplasias/genética , RecQ Helicasas/genética , Síndrome de Werner/genética , Adulto , Edad de Inicio , Neoplasias Colorrectales/epidemiología , Neoplasias Colorrectales/genética , Neoplasias Colorrectales/fisiopatología , Femenino , Predisposición Genética a la Enfermedad/epidemiología , Hawaii/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Tasa de Mutación , Neoplasias/epidemiología , Neoplasias/fisiopatología , Polimorfismo Genético , Prevalencia , Medición de Riesgo , Síndrome de Werner/epidemiología , Helicasa del Síndrome de Werner
4.
Am J Clin Pathol ; 118(6): 870-6, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12472280

RESUMEN

Proteomic studies of cells via surface-enhanced laser desorption/ionization spectrometry (SELDI) analysis have enabled rapid, reproducible protein profiling directly from crude samples. We applied this technique to archival cytology material to determine whether distinct, reproducible protein fingerprints could be identifiedfor potential diagnostic purposes in blinded specimens. Rapid Romanowsky-stained cytocentrifuged specimens from fine-needle aspirates of metastatic malignant melanoma (with both known cutaneous primary and unknown primary sites), clear cell sarcoma, and renal cell carcinoma and reactive effusions were examined using the SELDI technology. A unique characteristic fingerprint was identified for each disease entity. Fifteen "blinded" unknown samples then were analyzed. When the protein profilefingerprints were plotted against the known fingerprints for the aforementioned diagnoses, the appropriate match or diagnosis was obtained in 13 (87%) of 15 cases. These preliminary findings suggest a substantial potential for SELDI applications to specific pathologic diagnoses.


Asunto(s)
Carcinoma de Células Renales/química , Carcinoma de Células Renales/patología , Melanoma/química , Melanoma/patología , Proteoma/análisis , Sarcoma/química , Sarcoma/patología , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Humanos , Mapeo Peptídico , Conservación de Tejido
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...